Health Highlights: Jan. 10, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Poor Trial Results for Another Experimental Alzheimer's Drug
An experimental Alzheimer's drug that previously showed promise yielded disappointing results in three clinical trials.
The drug idalopirdine did not help people with mild to moderate Alzheimer's disease in the trials, which included 2,525 patients in 34 countries, the Los Angeles Times reported.
The findings were reported Tuesday in the Journal of the American Medical Association.
Previous clinical trials suggested the drug might be beneficial, but those trials focused mainly on the drugs' safety, the Times reported.
This is the latest failure in efforts to develop new drugs for Alzheimer's, which affects 5.5 million Americans. Someone in the U.S. is diagnosed with Alzheimer's every 66 seconds, according to the Alzheimer's Association.
There have been about 400 unsuccessful clinical trials of experimental treatments for Alzheimer's, the Times reported.
© 2020 HealthDay. All rights reserved.
Posted: January 2018
Read this next
THURSDAY, Oct. 29, 2020 -- Experts in healthy aging often cite the importance of leisure activities -- hanging out with friends, playing games, taking classes -- in maintaining...
MONDAY, Oct. 26, 2020 -- If you're a senior who can't smell onions, smoke, chocolate or natural gas, it's time to see your doctor. Seniors who lose their sense of smell -- which...
TUESDAY, Oct. 20, 2020 -- As the air people breathe gets dirtier, their odds for serious neurological disorders such as Parkinson's disease, Alzheimer's and other dementias rises,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.